140 related articles for article (PubMed ID: 38613405)
1. Comprehensive characterization of somatic mutations associated with chimeric RNAs in human cancers.
Wang Y; Shu M; Wang T; He T; Yuan J; Yang Y
Int J Cancer; 2024 Aug; 155(4):683-696. PubMed ID: 38613405
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive characterization of somatic variants associated with intronic polyadenylation in human cancers.
Zhao Z; Xu Q; Wei R; Huang L; Wang W; Wei G; Ni T
Nucleic Acids Res; 2021 Oct; 49(18):10369-10381. PubMed ID: 34508351
[TBL] [Abstract][Full Text] [Related]
3. Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types.
Seiler M; Peng S; Agrawal AA; Palacino J; Teng T; Zhu P; Smith PG; ; Buonamici S; Yu L
Cell Rep; 2018 Apr; 23(1):282-296.e4. PubMed ID: 29617667
[TBL] [Abstract][Full Text] [Related]
4. Rules and tools to predict the splicing effects of exonic and intronic mutations.
Ohno K; Takeda JI; Masuda A
Wiley Interdiscip Rev RNA; 2018 Jan; 9(1):. PubMed ID: 28949076
[TBL] [Abstract][Full Text] [Related]
5. Intron retention is a widespread mechanism of tumor-suppressor inactivation.
Jung H; Lee D; Lee J; Park D; Kim YJ; Park WY; Hong D; Park PJ; Lee E
Nat Genet; 2015 Nov; 47(11):1242-8. PubMed ID: 26437032
[TBL] [Abstract][Full Text] [Related]
6. Pan-cancer analysis of whole genomes.
ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium
Nature; 2020 Feb; 578(7793):82-93. PubMed ID: 32025007
[TBL] [Abstract][Full Text] [Related]
7. Using RNA-Seq Data for the Detection of a Panel of Clinically Relevant Mutations.
Wolff A; Perera-Bel J; Schildhaus HU; Homayounfar K; Schatlo B; Bleckmann A; Beißbarth T
Stud Health Technol Inform; 2018; 253():217-221. PubMed ID: 30147077
[TBL] [Abstract][Full Text] [Related]
8. Chimeric RNAs generated by intergenic splicing in normal and cancer cells.
Jividen K; Li H
Genes Chromosomes Cancer; 2014 Dec; 53(12):963-71. PubMed ID: 25131334
[TBL] [Abstract][Full Text] [Related]
9. Chimeric RNAs Discovered by RNA Sequencing and Their Roles in Cancer and Rare Genetic Diseases.
Sun Y; Li H
Genes (Basel); 2022 Apr; 13(5):. PubMed ID: 35627126
[TBL] [Abstract][Full Text] [Related]
10. Splicing Factor Mutations in Cancer.
Bejar R
Adv Exp Med Biol; 2016; 907():215-28. PubMed ID: 27256388
[TBL] [Abstract][Full Text] [Related]
11. Interaction Landscape of Inherited Polymorphisms with Somatic Events in Cancer.
Carter H; Marty R; Hofree M; Gross AM; Jensen J; Fisch KM; Wu X; DeBoever C; Van Nostrand EL; Song Y; Wheeler E; Kreisberg JF; Lippman SM; Yeo GW; Gutkind JS; Ideker T
Cancer Discov; 2017 Apr; 7(4):410-423. PubMed ID: 28188128
[TBL] [Abstract][Full Text] [Related]
12. Chimeric RNAs in cancer.
Shi X; Singh S; Lin E; Li H
Adv Clin Chem; 2021; 100():1-35. PubMed ID: 33453863
[TBL] [Abstract][Full Text] [Related]
13. Whole-exome sequencing to identify novel somatic mutations in squamous cell lung cancers.
Zheng CX; Gu ZH; Han B; Zhang RX; Pan CM; Xiang Y; Rong XJ; Chen X; Li QY; Wan HY
Int J Oncol; 2013 Sep; 43(3):755-64. PubMed ID: 23799614
[TBL] [Abstract][Full Text] [Related]
14. Chimeric RNAs as potential biomarkers for tumor diagnosis.
Zhou J; Liao J; Zheng X; Shen H
BMB Rep; 2012 Mar; 45(3):133-40. PubMed ID: 22449698
[TBL] [Abstract][Full Text] [Related]
15. Indel sensitive and comprehensive variant/mutation detection from RNA sequencing data for precision medicine.
Prodduturi N; Bhagwate A; Kocher JA; Sun Z
BMC Med Genomics; 2018 Sep; 11(Suppl 3):67. PubMed ID: 30255803
[TBL] [Abstract][Full Text] [Related]
16. Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes.
Sveen A; Kilpinen S; Ruusulehto A; Lothe RA; Skotheim RI
Oncogene; 2016 May; 35(19):2413-27. PubMed ID: 26300000
[TBL] [Abstract][Full Text] [Related]
17. Combining full-length gene assay and SpliceAI to interpret the splicing impact of all possible SPINK1 coding variants.
Wu H; Lin JH; Tang XY; Marenne G; Zou WB; Schutz S; Masson E; Génin E; Fichou Y; Le Gac G; Férec C; Liao Z; Chen JM
Hum Genomics; 2024 Feb; 18(1):21. PubMed ID: 38414044
[TBL] [Abstract][Full Text] [Related]
18. Germline cytoskeletal and extra-cellular matrix-related single nucleotide variations associated with distinct cancer survival rates.
Falasiri S; Rahman T; Tu YN; Fawcett TJ; Blanck G
Gene; 2018 Aug; 669():91-98. PubMed ID: 29778426
[TBL] [Abstract][Full Text] [Related]
19. Autologous reference types can confound the detection of somatic mutation in solid cancers.
Chen X; Zou X; Zhong W; Peng K; Wang D; Fan W; Lin J; Peng J
DNA Repair (Amst); 2018 Sep; 69():6-13. PubMed ID: 30029072
[TBL] [Abstract][Full Text] [Related]
20. A pan-cancer analysis of transcriptome changes associated with somatic mutations in U2AF1 reveals commonly altered splicing events.
Brooks AN; Choi PS; de Waal L; Sharifnia T; Imielinski M; Saksena G; Pedamallu CS; Sivachenko A; Rosenberg M; Chmielecki J; Lawrence MS; DeLuca DS; Getz G; Meyerson M
PLoS One; 2014; 9(1):e87361. PubMed ID: 24498085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
